Clinical Trials for Antihypertensive Drugs: Implications of Introducing Telemetric Self-measured Blood Pressure
- PDF / 10,842,504 Bytes
- 9 Pages / 612 x 792 pts (letter) Page_size
- 65 Downloads / 187 Views
Volkrr MSckeI, PbD MSc Clinical Trial Head, Novartis Phanna AG. Basel, Switzdand Adityo h b l , MS Senior Insights Manager, Novartis Phanna AG. Basel, Switzerland
Jobm Vorakllr, BSc Head Operationsand Innovationfor TM. Novartis Phanna AG, Basel. Switzerland Albrrt Koodro, MSc Expert Statistician. Novartis Phanna AG. Basel. Switzerland Kry Words Antihypertensive clinical trial; Innovative trial design: Self-measured blood pressure; Telemedicine; Telemetric blood pressure Correrpoodrocr Addrrrs Vdker Mwkel. PhD. Clinical Trial Head, Novartis Phanna AG. Pwtfach. CH-4056 Basel. Switzerland (email: [email protected]).
The Drug InformationAssociation is accredited by the Accreditation Councilfor Continuing Medical Education (ACCME) to provide continuing medical educationfor physicians.
7he Drug InformationAssociation designates this educational activity for a maximum of I AMA PRA Cotegory 1 credit(^)^^. Physicians should only claim credit commensurate with the extent oftheir participation in the activity
H
The Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This progmm is designatedfor a maximum of I contact hour or. I continuing education units (CEUs). 286-00009-021 - H 0 4
lfyou would like to receive a statement ofmdit.you must review theartide. and complete the posttest and evaluation included on the DIA website. Participants must receive a passingsconof8O%orbelteron the posttest in order to receive a statement ofcredit. To access the posttest and evaluation. please visit the DIA website at m.diahome.org. select Educational 0ffin.ngs. and then select Continuing Education j b n the drop down menu, and the My Transcript link. This will takeyou to the My Transcript page whereyou will be pmmptd to sign in usingyour DIA uscmamc and password. Once signed in,you may select the article 'Uinical Trialsfor Antihypertensive Drugs: Implications of Introducing Telemetric Self-memuredBlood Pressure. " You will be prompted to complete the posttst and evaluation. Upon successfil completion ofthe posttest. you will be able to downloadyour statement ofcredit. lfyou are not a DIA customer.please contact the DIA office at [email protected] for a registration fonn. There is no fee to receiveyour statement ofcredit.
233
Clinical Trials for Antihypertensive Drugs: Implications of Introducing Telemetric Self-measured Blood Pressure Diagnostic devices for self blood pressure (BP) measurement at home can be coupled with telemetric data transmission to make patient's BP measurements available online for treating physicians. Once applied successfullr,this new approach will have widespread implicationsfor the diagnosis and monitoringof the pharmacological treatment of patients in antihypertensive clinical trials. Safety monitoring of BP might be optimized throughout the trial while the trial design itself could be streamlined. In case data are meant to be used for regulatory . submissions, the capture and analysis of tele-
metric da
Data Loading...
